The cost of antibiotic resistance from a bacterial perspective

Drug Resistance Updates

Volumn 3, Issue 4, 2000, Pages 237-245

  Björkman, Johanna ^a   Andersson, Dan I ^a  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; DRUG COST; DRUG USE; EVOLUTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS GROUP A;

EID: 0033830225     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1054/drup.2000.0147     Document Type: Article

References (54)

1. Epidemiology of emerging/re-emerging antimicrobial-resistant bacterial pathogens
2. The population genetics of antibiotic resistance
3. Understanding, predicting and controlling the emergence of drug-resistant tuberculosis: A theoretical framework
4. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance
5. Evaluating treatment protocols to prevent antibiotic resistance
6. Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of infection control programs
7. Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models
8. From the cover: The epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptions
9. Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci
10. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance
11. Conditions for the existence of R-plasmids in bacterial populations
12. To be a mutator, or how pathogenic and commensal bacteria can evolve rapidly
13. High mutation frequencies among Escherichia coil and Salmonella pathogens
14. High frequency of hypermutable Pseudomonos oeruginosa in cystic fibrosis lung infection
15. Proliferation of mutators in a cell population
16. Evidence that gene amplification underlies adaptive mutability of the bacterial lac operon
17. Recombination between short DNA homologies causes tandem duplication
18. The biological cost of antibiotic resistance
19. Development of betalactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993
20. Compensatory evolution in rifampin-resistant E. coli
21. The limitations of translational accuracy
22. The dynamic structure of EF-G studied by fusidic acid resistance and internal revertants
23. Survival of rifampin-resistant mutants of Pseudomonas fiuorescens and Pseudomonas putida in soil systems
24. Characterization of the pleiotropic phenotypes of rifampin-resistant rpoB mutants of Escherichia coli
25. Amelioration of the deleterious pleiotropic effects of an adaptive mutation in Bacillus subtilis
26. Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis
27. Drug-resistant strains of Mycobocterium tuberculosis exhibit a range of virulence for mice
28. Effect of inhA and katG on isoniazid resistance and virulence of Mycobocterium bovis
29. Reducing antibiotic resistance
30. Adaptation to sulfonamide resistance in Neisseria meningitidis may have required compensatory changes to retain enzyme function: Kinetic analysis of dihydropteroate synthases from N. meningitidis expressed in a knockout mutant of Escherichia coli
31. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli
32. Virulence of antibiotic-resistant Salmonella typhimurium
33. Fitness costs associated with class IIa bacteriocin resistance in Listeria monocytogenes B73
34. Expression of katG in Mycobacterium tuberculosis is associated with growth and persistence in mice and guinea pigs
35. Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis
36. Novel ribosomal mutations affecting translational accuracy, antibiotic resistance and virulence of Salmonella typhimurium
37. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance
38. The influence of the growth environment on the stability of a drug resistance plasmid in Escherichia coil K 12
39. Generation time-prolonging R plasmids: Correlation between increases in the generation time of Escherichia coil caused by R plasmids and their molecular size
40. The maintenance of plasmid-containing organisms in populations of Escherichia coli
41. Expression of tetracycline resistance in pBR322 derivatives reduces the reproductive fitness of plasmid-containing Escherichia coli
42. Evolution of a bacteria/plasmid association
43. Plasmid expression and maintenance during long-term starvation-survival of bacteria in well water
44. Parameters affecting plasmid stability in Bacillus subtilis
45. Coevolution in bacteria-plasmid populations
46. Plasmid macrevolution: Selection of deletions during adaptation in a nutrient-limited environment
47. Adaptation of Escherichia coli growth rates to the presence of pBR322
48. Genetic changes accompanying increased fitness in evolving populations of Escherichia coli
49. Genetic analysis of a plasmid-encoded, host genotype-specific enhancement of bacterial fitness
50. E. coli growth inhibition by a high copy number derivative of plasmid pBR322
51. Compensatory ahpC gene expression in isoniazid-resistant Mycobocterium tuberculosis
52. Viral mutation and evolution accelerated by nitric oxide-induced oxidative stress
53. Fitness of antibiotic-resistant microorganisms and compensatory mutations
54. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria